Objective: Cerebral perfusion pressure <40 mm Hg following pediatric traumatic brain injury has been associated with increased mortality independent of age, and current guidelines recommend maintaining cerebral perfusion pressure between 40 mm Hg-60 mm Hg. Although adult traumatic brain injury studies have observed an increased risk of complications associated with targeting a cerebral perfusion pressure >70, we hypothesize that targeting a cerebral perfusion pressure of 70 mm Hg with the use of phenylephrine early after injury in the immature brain will be neuroprotective.
E arly posttraumatic brain injury (TBI) cerebral hypoperfusion may greatly contribute to secondary brain injury, and therefore morbidity and mortality (1) . Low cerebral blood flow (CBF) states have been demonstrated in children by xenon computed tomograph scans following TBI within 24 hrs of the initial injury, but by 48 hrs these patients had normal or supernormal blood flows (1) . More recently, a retrospective study of children with severe TBI observed that poorer outcomes were correlated with early low CBF (2) . A retrospective study of 146 pediatric TBI patients observed a strong association of poor outcome at discharge with hypotension within the first 6 hrs of injury (3) . The window for treatment of hypoperfusion appears to be early after pediatric TBI, and may be of relatively short duration in children.
Currently, pediatric cerebral perfusion pressure (CPP) thresholds used in the ICU environment (40 mm Hg-60 mm Hg) have been extrapolated from adult experimental and clinical TBI and stroke studies (4, 5) . Chambers et al (6) (7) (8) , have published much needed age-specific pediatric thresholds for critical CPP, below which cerebral ischemia occurs with unfavorable neurologic outcomes and increased mortality. These studies identified inadequate CPP levels but did not identify an "optimal treatment" CPP, and therefore assumed that these CPP levels were equivalent to brain injury insult thresholds. Use of currently accepted pediatric CPP guidelines (CPP >40 mm Hg) does not ensure adequate oxygen delivery to brain tissue (9, 10) . This raises the question: Is a CPP >40 mm Hg in the pediatric TBI patient high enough, and should this target CPP be modulated over time with a higher CPP set early after injury? Mild induced hypertension after ischemic stroke has shown promise in animal models but remains controversial in the clinical setting (11, 12) . Adult TBI studies have observed an increased risk of adult respiratory distress syndrome associated with targeting a CPP >70 mm Hg, but it is unclear how applicable this is to the early resuscitation of the head-injured child (13, 14) .
Initial stabilization of the pediatric TBI patient may occur in limited resource environments where complex invasive intracranial monitoring may not be available. Early stabilization of cerebrovascular hemodynamics with a vasopressor, such as phenylephrine, and targeting a higher mean arterial pressure (MAP) or CPP may reduce brain injury and improve long-term outcomes. We have previously developed a novel critical care model of pediatric closed head injury that utilizes a large animal model to enable full clinical modalities used in neuro-intensive care (15) . In this study, we tested the hypothesis that targeting a higher CPP (70 mm Hg vs. 40 mm Hg) with the use of phenylephrine early after TBI in our immature swine model would be neuroprotective.
MATERIAL AND METHODS
Animal Preparation. All protocols were approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Four-week-old female piglets whose brain development, myelination, and cerebrovascular responses correspond to the human toddler were studied (16, 17) . Piglets were anesthetized with an intramuscular injection of ketamine (20 mg/kg) and xylazine (2 mg/kg) followed by inhaled 4% isoflurane. Vitals signs including heart rate, blood pressure, respiratory rate, end-tidal CO 2 , pulse oximetry, and rectal temperature were monitored continuously and recorded every 15 mins. Rectal temperature was maintained between 37.5ºC-38.5ºC using a heating pad.
Piglets were orally intubated and mechanically ventilated (positive end expiratory pressure of 5 mm Hg, tidal volume 10-12 mL/ kg). Femoral artery and venous catheters were placed for continuous MAP monitoring, arterial blood gas sampling, and IV fluid administration. Animals were administered 50 mcg/kg fentanyl IV, followed by a fentanyl infusion (50 mcg/kg/hr) and normal saline (4 mL/kg/hr) (18) . Following initiation of the fentanyl infusion, isoflurane was reduced to 0.5%-1%. Mechanical ventilation was adjusted to maintain end-tidal CO 2 between 35-40 mm Hg and Fio 2 was maintained between 28%-30%. Preinjury and postinjury arterial blood gas samples were obtained hourly (Nova Biomedical, Waltham, MA) until euthanasia 6 hrs after injury.
Nonimpact Rotational Brain Injury. Animals were randomized to either a goal CPP of 70 mm Hg (CPP70, N = 10), or 40 mm Hg (CPP40, N = 11). Animals experienced rapid axial head rotations without impact (angle rotation 90° over 10-12 msec) as described previously (19) (20) (21) . Immediately prior to injury, isoflurane was discontinued. Angular velocity was measured using an angular rate sensor (ATA, Albuquerque, NM) attached to the linkage sidearm. After injury, mechanical ventilation was continued and latency to return of pinch reflex following injury was recorded and isoflurane 0.5%-1% was resumed. The animal was removed from the bite-plate and placed in the prone position.
Neuromonitoring. After injury, four burr holes were prepared for placement of fiberoptic intracranial pressure monitor, brain tissue oxygen monitor, and microdialysis probe. The fiber-optic intracranial pressure probe (Integra, Plainsboro, NJ) was secured with a single lumen bolt. The Licox catheter system (Integra) was placed to measure brain tissue oxygenation (PbtO 2 ). The brain tissue oxygen probe was inserted to a depth of 1.5 cm, secured with bone wax, and allowed to equilibrate for 30 mins before values were recorded. A hyperoxia test was performed to confirm proper catheter placement. Data for intracranial pressure and PbtO 2 were recorded every 15 mins until killed.
A microdialysis probe (Polyethersylphone 12, 4mm length; CMA, North Chelmsford, MA) was placed on the opposite side of the skull from the PbtO 2 catheter into subcortical white matter. Immediately after insertion, the probe was infused with sterile 0.9% NaCl at a rate of 1 µL/min. Dialysate samples were collected every 30 mins until killed and stored at −80°C and analyzed for lactate and pyruvate using a CMA600 analyzer (CMA).
A CBF thermal diffusion probe (Hemedex, Cambridge, MA) was inserted to a depth of 1.5 cm in half of the animals in each group (CPP70, N = 5; CPP40, N = 6) and data were recorded every 15 mins until killed. A separate group of injured animals (N = 5) and instrumented shams (SHAM, N = 4) underwent CBF monitoring as reference groups for CBF values without CPP modulation.
Cerebral Perfusion Modulation. There are limited data on the comparative effectiveness of commonly used vasopressors in adult and pediatric TBI. Phenylephrine has been reported to be the most commonly used vasopressor for CPP modulation after TBI in both adult and pediatric retrospective studies and was chosen for these studies (22, 23) . Due to the lack of data supporting or refuting targeting a CPP of 70 mm Hg in children or immature animals early after TBI, we designed our study to compare the accepted limits of the therapeutic range (40 mm Hg-70 mm Hg). One hour after injury, phenylephrine infusions were initiated and titrated to goal CPP (either 40 mm Hg or 70 mm Hg) until euthanasia 6 hrs after injury.
Histology. At 6 hrs postinjury, animals were killed via an overdose of pentobarbital. Brains were perfusion-fixed, and two 6-μm sections were cut from every 3-mm block. Sections were stained with hematoxylin and eosin, or with the immunohistochemical markers for axonal injury beta-amyloid precursor protein (β-APP) (Chemicron 22C11 used at dilution of 1:5000, Millipore, Billerica, MA) and counterstained with Meyer's hematoxylin. Areas of cell injury on hematoxylin and eosin staining were identified by changes in staining intensity, and characterized by cell shrinkage and cytoplasmic eosinophilia (24) . Regions of β-APP reactivity and cell injury were noted by a blinded neuropathologist and the locations of white matter damage and cell injury were traced in each slice using our previously described procedure to determine total area (15) . Total and injured areas were multiplied by section thickness to determine total and injured brain volumes.
Statistical Analysis. Physiological, arterial blood gas, and neuromonitoring parameter (intracranial pressure, PbtO 2 , microdialysis, and CBF) data were analyzed across groups and time using repeated measures analysis of variance tests and Tukey-Kramer tests, were used for post hoc analysis with significance defined as p < .05. Six hour values for lactate pyruvate ratios (LPR) and PbtO 2 were compared to previously reported historical controls for injured and sham animals with analysis of variance tests. Dunnett's tests were employed to determine statistical significance of physiological data and intracranial monitoring values preadministration and postadministration of phenylephrine. Neuropathology comparisons between groups were analyzed using Student's t test. All values are expressed as mean ± se. A post-hoc power analysis was performed. Based on our previous results in injured animals, to detect a 3% difference in injury volumes with 80% power, a total of 20 animals (10 in each group) would be required (15) .
RESULTS
Injury and Physiological Data. Angular peak velocity was similar between the two groups (CPP70, 171.7 ± 3.3 rad/s vs. CPP40, 170.2 ± 2.1 rad/s, p = .77). Average unconscious time (return of pinch reflex) was also similar between the two groups (CPP70, 15.4 ± 2.5 min vs. CPP40, 15.7 ± 1.9 min, p = .81). Physiological and arterial blood gas data for CPP40 and CPP70 are shown in Tables 1 and 2 respectively. MAP was significantly higher in CPP70 after initiation of phenylephrine 1 hr after injury, but there were no observed increases in arterial lactate levels due to phenylephrine administration (Table 2 ). Of note, we observed a baseline metabolic alkalosis in our animals (consistent with previous reports) and adjusted our goal PaCO 2 to 40 mm Hg-45 mm Hg (25) .
Phenylephrine dosing requirements for CPP70 were significantly higher compared to CPP40 (Table 3) , but no significant changes in intracranial pressure were noted in either group after the initiation of phenylephrine ( Fig. 1 ). CPP was significantly higher for CPP70 compared to CPP40, and goal CPP was achieved and maintained in both groups (Fig. 2) .
Intracranial Monitoring. In order to assess temporal responses to CPP modulation, we measured PbtO 2 , microdialysate LPR as a measure of cellular metabolism, and CBF. PbtO 2 was higher for CPP70 compared to CPP40 after the initiation of phenylephrine but did not reach statistical significance (Fig. 3 ). PbtO 2 responded to CPP modulation and was significantly higher during the postinjury interval of 2-6 hrs compared to initial values measured within 1 hr of injury in CPP70, and during the postinjury interval of 3.5-5 hrs in CPP40 (Fig. 3) .
After initiation of phenylephrine, CPP70 had significantly lower LPR compared to CPP40 p < .05 ( Fig. 4) . CPP modulation to 70 mm Hg resulted in significantly lower LPR levels during the postinjury interval 2-6 hrs compared to initial values measured within 1 hr of injury. There was no correlation between serum and microdialysate lactate levels.
Repeated measures analysis of variance of CBF revealed significant group, time, and group × time effects ( Fig. 5 ) (p < .05). Subsequent Tukey-Kramer analysis demonstrated CBF for CPP70 was significantly higher compared to untreated injured animals. (p < .05). CPP40 CBF was lower than CPP70 after phenylephrine initiation but did not reach statistical significance. Dunnett's test for CPP70 demonstrated significantly higher CBF during the postinjury interval 1.5-6 hrs compared to initial postinjury values. Similarly, CPP40 CBF was higher during postinjury interval 3-5 hrs compared to initial postinjury values.
Neuropathology. Neuropathology revealed regions of injury predominantly in the frontal and parietal lobes. Traumatic axonal injury volumes at 6 hrs postinjury as determined by β-APP immunohistochemistry were not different between the two groups ( Fig. 6 ). Cell injury volumes determined by H&E were significantly larger in CPP40 compared to CPP70 (Fig. 6 ). Regions of cell injury were predominantly observed in cortical regions of the frontal lobes.
DISCUSSION
In the present study, the objective was to use our previously described clinically relevant large animal model of pediatric neurocritical care to evaluate early CPP augmentation with phenylephrine following nonimpact inertial head injury (15) . Our immature swine model has the advantage of similar brain structure and development as the pediatric brain, and the brain size can accommodate neuromonitoring equipment utilized in the pediatric intensive care unit. Since there is currently no data supporting or refuting utilizing a CPP of 70 mm Hg in children or immature animals early after TBI, we chose to compare the accepted limits of the therapeutic range (40 mm Hg-70 mm Hg). Arterial blood gas data pre-injury, 1 hr, 3 hrs and 6 hrs post-injury. ± sd.
Physiologic Effects of Phenylephrine. Phenylephrine infusions were successfully titrated to reach goal CPP. The larger dosing of phenylephrine required to achieve the higher CPP was well tolerated without signs of systemic tissue hypoperfusion (arterial lactate levels, Table 2 ), although animals were only exposed to phenylephrine for 5 hrs. Heart rates of animals in both groups gradually increased over the 6-hr observation period, which we believe is due to the known tachycardia associated with fentanyl infusions in immature swine and not attributable to phenylephrine (26) . Previous studies in adult swine reported worsening pulmonary edema with phenylephrine administration for CPP support (27) , but we did not observe any changes in PaO 2 or Fio 2 requirements. Peak MAPs achieved in the CPP70 group were within the normal range of awake immature swine (25) . Phenylephrine requirements to maintain goal CPP were higher than typically observed in children but lower than reported in adult swine models of TBI and hemorrhagic shock (28, 29) . These differences may be due to our use of volatile anesthetics, the age of the animals, and/or variations in pharmacodynamics of phenylephrine across species.
Early Phenylephrine Titration to Higher CPP Reduces Cell Injury. Our model tests whether early relative hypoperfusion contributes to the severity of secondary brain injury before significant intracranial hypertension is observed. In our model, animals had only mild intracranial hypertension in the early hours after injury; however we observed significant areas of cell injury on H&E examination. Manipulation of CPP from 40 mm Hg to 70 mm Hg resulted in significantly lower cell injury volumes, but there were no differences in traumatic axonal injury volumes as assessed by β-APP immunohistochemistry. We hypothesize that these areas of cell injury we observed and reported previously result from decreased perfusion and metabolic crisis in specific cortical regions (15) , correlating well with the regions affected in children with TBI undergoing long-term follow-up (30) .
CPP Augmentation With Phenylephrine Improves Pbto 2 Following Nonimpact Inertial Head Injury. Phenylephrine infusions significantly improved PbtO 2 in both groups. There are several possible explanations for the lack of significant difference between the two groups. PbtO 2 is a small regional measurement, and in our model, probes were inserted to a depth of Phenylephrine dosing and cerebral hemodynamics, 2, 4, and 6 hrs post-injury. a statistically significant difference compared to cerebral perfusion pressure 40, p < .01 with Tukey-Kramer post-hoc analysis. ± sd 1.5 cm into the subcortical white matter of the frontal lobe. In these regions we observed no difference in axonal injury by β-APP immunohistochemistry between groups. However, differences in injury volumes between the groups were observed on H&E examination in regions closer to the brain surface away from the region of PbtO 2 detection in our model. Increased PbtO 2 in regions of injury may represent an improvement in oxygen delivery, lower oxygen utilization due to altered cellular metabolism, or a combination of both. The fidelity of PbtO 2 monitoring is probably insufficient to be used as a single marker to detect or describe all the effects of early CPP modulation on the reduction of secondary brain injury.
CPP Augmentation to 70 mm Hg Early After Injury Improves Brain Cellular Metabolism. Cellular metabolism as measured by cerebral microdialysis LPR was significantly improved in CPP70 compared to CPP40. This would suggest an increase in substrate delivery with aggressive CPP augmentation. Microdialysis sampling can create concentration gradients which extends the region of brain tissue being measured several millimeters out from the probe site (31) . This is much further than PbtO 2 , which may explain the lack of statistical significance of our PbtO 2 measurements between the two groups. Our findings of improvement in LPR with CPP augmentation are contrary to findings observed in the peri -contusional tissue of adult head injured patients (32) , but the pathophysiology and response to rises in MAP may differ in a nonimpact diffuse injury model.
Phenylephrine Improves CBF Following Nonimpact Head Injury. Previous TBI studies in swine and humans have demonstrated improvement in PbtO 2 after CPP augmentation but have not directly measured CBF (29, 33) . Utilizing a thermal diffusion probe placed in the subcortical white matter, we were able to record repeated measurements of quantitative CBF over time. Along with improvement in PbtO 2 and cellular metabolism, we observed significant increases in quantitative CBF. These increases in CBF were not associated with increases in intracranial pressure, which has been previously reported in a rat model (34) . Targeting a CPP of 70 mm Hg resulted in higher CBF with values approaching CBF levels in anesthetized uninjured animals. It should be noted that the observed average PaCO 2 was slightly higher than current recommended guidelines, which may alter CBF, although there were no statistical differences in PaCO 2 between the groups. We conclude that CPP augmentation with phenylephrine early after TBI in an immature swine model increases CBF, correcting hypoperfusion, reducing cellular metabolic crisis, improving PbtO 2 , and resulting in a reduction in cell injury volumes.
Limitations of the Study. There are several limitations to our experimental design which must be considered when translating our results to the care of the pediatric patient with TBI. First, our model of nonimpact inertial head injury does not encompass the complete heterogeneity of pediatric TBI, specifically focal contusions. The pathophysiology and responses to CPP augmentation in uninjured, pericontusional, and "core" contusion brain tissue may differ from what we have observed in our diffuse injury model. Second, the effects of volatile anesthetics on cerebral autoregulation and neuroprotection are well described, and may influence phenylephrine's effects on CBF and cell injury volumes (35, 36) . We are currently developing an anesthetic plan for our model which avoids inhaled anesthetics and mimics sedation typically utilized in the pediatric intensive care unit. Third, although we did not observe changes in arterial oxygenation, intracranial pressure, or serum lactate with phenylephrine administration, brain and lung water content were not measured. Increases in lung water content after phenylephrine administration for CPP augmentation have been reported in adult swine (27) . It is unclear if immature swine have different phenylephrine pharmacodynamics and toxicity tolerances. Fourth, the observation period was only a total of 6 hrs after injury, limiting our outcome measures to multimodal intracranial monitoring and acute neuropathology and lacking neurobehavioral functional outcomes. In future studies we plan to develop longer survival times and apply our previously developed neurobehavioral outcome measures (19, 37) . Pediatric TBI patients may need vasopressor support for several days after injury, and it is still unclear whether CPP augmentation with vasopressors and target CPP should change as the injury evolves over time. Fifth, we chose a relatively short delay in administration of phenylephrine after injury, and further investigations are needed to examine the length of the therapeutic window. Sixth, we only utilized female swine in our study. Sex-dependent differences in the response of CBF autoregulation to phenylephrine administration after TBI have been reported in swine, and our results may not be generalizable to male swine (38, 39) . Future studies to examine the role of sex in our nonimpact head injury model are planned. Seventh, there are a multitude of approaches to the augmentation of CPP; including different vasopressors, colloid and crystalloid administration, and hyperosmolar therapy. We chose phenylephrine since it is a commonly used vasopressor in pediatric TBI (23) . Future studies will evaluate other means of CPP augmentation. Finally, we chose to study only two target CPP levels, a CPP of 40 mm Hg and 70 mm Hg which are at or beyond the extremes of current guideline recommendations (40) . It is possible that a CPP between these two groups may effectively reduce metabolic crisis, improve CBF, and reduce cell injury, with less risk of systemic side effects.
CONCLUSION
In our swine model of pediatric closed head injury we observe early derangements in CBF, PbtO 2 , cellular metabolism, and acute neuropathology. Early administration of phenylephrine improved cerebral metabolism, CBF, and PbtO 2 . Targeting a CPP of 70 mm Hg resulted in a greater reduction in metabolic crisis and cell injury volumes compared to a CPP of 40 mm Hg, but did not result in statistically significant differences in CBF and PbtO 2 in a swine model of pediatric TBI. Early aggressive CPP augmentation to a CPP of 70 mm Hg in pediatric TBI before severe intracranial hypertension may be neuroprotective, and further investigations are needed.
